Hybrid Group Singing for Coronary Artery Disease
This study is exploring whether singing can improve heart health in older adults with coronary artery disease (CAD). Researchers are testing two singing programs: a 12-week "hybrid group singing" program (a mix of in-person and online sessions, three times a week) and a 12-week "instructional sing-along video series" (done independently at home, three times a week). The main goal of this particular study is to see how well people stick to these singing programs. You might be able to join if you are between 55 and 89 years old, have a history of CAD (like a heart attack, stent, or bypass surgery), and do not have certain conditions like Parkinson's disease or current tobacco use. The study aims to enroll 32 participants, but its current status is unclear.
- Study design
- This is an interventional study with a planned enrollment of 32 participants. It compares two different singing interventions.
- What's involved
- Participants will engage in either hybrid group singing or an instructional sing-along video series, three times weekly for 12 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Adherence to the singing programs will be measured at 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Hybrid Group Singing
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Adherence12 weeks
The mean percent of sessions attended.